Please note: In order to keep Hive up to date and provide users with the best features, we are no longer able to fully support Internet Explorer. The site is still available to you, however some sections of the site may appear broken. We would encourage you to move to a more modern browser like Firefox, Edge or Chrome in order to experience the site fully.

Novel Biomarkers in the Continuum of Breast Cancer, Paperback / softback Book

Novel Biomarkers in the Continuum of Breast Cancer Paperback / softback

Edited by Vered Stearns

Part of the Breast Cancer Research Foundation series

Paperback / softback

Description

This volume provides a comprehensive review of established and novel biomarkers across the continuum of breast cancer.

The volume covers topics related to breast cancer risk and prevention, prediction of response to today’s standard therapies, and markers capable of influencing treatment decisions in the near future.

Chapter authors combine their wide-ranging expertise to review the current status of the biomarker and to offer their individual perspectives on how biomarkers may be used in future treatments and research. Breast cancer continues to be the most common malignancy diagnosed in women in the Western world.

While there are multiple treatment approaches for breast cancer, today more than ever we recognize that each tumor is unique.

The challenge ahead is to consider how to best use validated and novel biomarkers to select the most appropriate treatment(s) for individual patients.

Information

Save 12%

£89.99

£78.79

 
Free Home Delivery

on all orders

 
Pick up orders

from local bookshops

Information

Also in the Breast Cancer Research Foundation series